Review badges
0 pre-pub reviews
0 post-pub reviews
Abstract

Nusinersen is a novel therapy for spinal muscular atrophy (SMA) type 1. Thus, the adverse reactions of the therapy have not been well established. We present here a 5-months old boy with SMA type 1, who developed hyponatremia after a single dose of nursinersen which has been rarely reported previously.

Authors

Coban, Yasemin;  Aslan, Nagehan;  Yildizdas, Dincer;  Horoz, Ozden Ozgur;  Mert, Gulen Gul

Publons users who've claimed - I am an author
Contributors on Publons
  • 2 authors